Acorah Software Products - Accounts Production 19.4.351 false true false true No description of principal activity 24 March 2025 28 February 2026 28 February 2026 16336712 Dr. R Harmse Mr D Anderson iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 16336712 2025-03-23 16336712 2026-02-28 16336712 2025-03-24 2026-02-28 16336712 frs-core:CurrentFinancialInstruments 2026-02-28 16336712 frs-bus:PrivateLimitedCompanyLtd 2025-03-24 2026-02-28 16336712 frs-bus:FilletedAccounts 2025-03-24 2026-02-28 16336712 frs-bus:Micro-entities 2025-03-24 2026-02-28 16336712 frs-bus:AuditExempt-NoAccountantsReport 2025-03-24 2026-02-28 16336712 frs-bus:Director1 2025-03-24 2026-02-28 16336712 frs-bus:Director2 2025-03-24 2026-02-28
Registered number: 16336712
Selsdon Veterinary Surgery Ltd
Financial Statements
For the Period 24 March 2025 to 28 February 2026
Balance Sheet
Registered number: 16336712
28 February 2026
£
Fixed assets 778
Current assets 4,287
Prepayments and accrued income 1,079
Creditors: Amounts Falling Due Within One Year (3,028 )
NET CURRENT ASSETS 2,338
TOTAL ASSETS LESS CURRENT LIABILITIES 3,116
Accruals and deferred income (3,050 )
NET ASSETS 66
CAPITAL AND RESERVES 66

Notes

1. General Information
Selsdon Veterinary Surgery Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 16336712 . The registered office is 24b The Grove, Biggin Hill, Westerham, TN16 3TB.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 3
3
For the period ending 28 February 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr. R Harmse
Director
14 August 2026